Top Markets
Coin of the day
Mabion S.A. Mabion S.A.

Mabion S.A.

MAB
Rangering i aksjer #27034
Mabion S.A. is a Polish biopharmaceutical firm dedicated to pioneering the... Mabion S.A. is a Polish biopharmaceutical firm dedicated to pioneering the development of biological drugs, primarily leveraging monoclonal antibody technology. The company oversees the full spectrum from research and development to the manufacturing and commercialization of therapies designed to combat a wide range of diseases, including neoplastic (cancer), autoimmune, metabolic, and neurological disorders. Key products in its portfolio include MabionCD20 and MabionHER2. Established in 2007, Mabion S.A. maintains its headquarters in Konstantynów Lódzki, Poland.
Aksjekurs
$2.19
Markedsverdi
$35.44M
Endring (1 dag)
1.96%
Endring (1 år)
-16.03%
Land
PL
Handel Mabion S.A. (MAB)

Kategori

Aksjeprishistorikk for Mabion S.A. (MAB)
Høyeste sluttskurs: $2.13 den 2026-08-01

Laveste sluttskurs: $4.20 den 2010-08-01
Aksjeprishistorikk for Mabion S.A. fra 2010 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) 12.10%
2025 -19.31%
2024 -48.95%
2023 -2.07%
2022 -70.98%
2021 195.71%
2020 -72.42%
2019 -11.04%
2018 -20.35%
2017 62.87%
2016 57.30%
2015 6.33%
2014 -9.21%
2013 146.12%
2012 58.68%
2011 -42.39%
2010 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$552.07 39.99%
US
$168.77 527.63%
US
$1.03K 56.22%
NL
$120.74 -14.98%
AU
$759.53 6.72%
CH